Mastorakos, G <br/><br/>
T4 but not T3 administration is associated with increased recurrence of Graves' disease after successful medical therapy.  [electronic resource] 

 -  Journal of endocrinological investigation  Oct 2003 
 - 979-84 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0391-4097 
<br/><br/><label>Standard No.: </label>10.1007/BF03348195  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antithyroid Agents--therapeutic use<br/>Autoantigens--blood<br/>Carbimazole--therapeutic use<br/>Female<br/>Graves Disease--blood<br/>Hormone Replacement Therapy--adverse effects<br/>Humans<br/>Iodide Peroxidase--blood<br/>Iron-Binding Proteins--blood<br/>Male<br/>Middle Aged<br/>Proportional Hazards Models<br/>Prospective Studies<br/>Recurrence<br/>Survival Analysis<br/>Thyrotropin--blood<br/>Thyroxine--administration & dosage<br/>Triiodothyronine--administration & dosage